
Israel's parliament on Monday approved a controversial bill to reintroduce the death penalty for terrorists, a move considered racist by critics as the legislation would effectively only apply to Palestinians.
Rights organizations and several European countries had called for the initiative to be stopped.
Under the bill, Palestinians convicted of murder as an act of terrorism by military courts in the occupied territories would face a mandatory death sentence.
In civilian courts in Israel, meanwhile, a person convicted of murder with a terrorism motive with the aim of destroying the State of Israel could be sentenced either to death or to life imprisonment under the law.
The bill was introduced by the Otzma Yehudit party of far-right Minister of National Security Itamar Ben-Gvir.
A total of 62 of 120 lawmakers in the Knesset backed the bill in a final vote on Monday, including Prime Minister Benjamin Netanyahu. A total of 48 lawmakers voted against the bill, while the rest abstained or were not present for the vote.
latest_posts
- 1
Earth's newfound 'episodic-squishy lid' may guide our search for habitable worlds - 2
Shelby County deputies charged with assault, placed on leave - 3
Transcript: NASA's Jared Isaacman on "Face the Nation with Margaret Brennan," April 5, 2026 - 4
Trump administration launches new immigration crackdowns in New Orleans and Minneapolis. Here are all the cities it has targeted so far. - 5
IDF destroys Hamas shaft in northern Gaza with loaded 'ready to fire' rocket aimed at Sderot
South Africa pushes for $200B investment
Israel Police arrest twenty-one as anti-war protests grow despite broad support for Iran war
German unemployment rate falls to 6.4%, but 3 million still jobless
Smuggler who called migrants 'chickens' jailed
The Best Computer games Ever
Here's what the Artemis 2 astronauts will be doing on each day of NASA's historic moon mission
Hundreds rally in West Bank against Israeli death penalty for Palestinians
Behind every perfect holiday memory is a mom on the brink
BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet












